PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Delivery of placenta-derived mesenchymal stem cells ameliorates ischemia induced limb injury by immunomodulation.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25562148 ↗2014Reported benefit

Delivery of placenta-derived mesenchymal stem cells ameliorates ischemia induced limb injury by immunomodulation.

MouseIschaemia-reperfusionLimb / skeletal muscleFemaleIntramuscular transplantation into the injured hind limb

Model: Hind limb ischaemia as a model of peripheral artery disease

Placenta-derived mesenchymal stem cells reduced acute muscle fibre apoptosis, lessened fibrosis and improved running capacity, with reduced inflammatory cell infiltration and pro-inflammatory cytokines and increased IL-10.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.